Article
Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis
2 Apr 2022
Abstract excerpt
BACKGROUND: Parthenolide has anti-inflammatory, immunomodulatory and anti-cancer activities. But its effect on thyroid cancer cells is still largely unknown. METHODS: Label-free quantitative proteomics and bioinformatics analysis were used to investigate the differentially expressed proteins and their functions in thyroid cancer treated with parthenolide and control pair. Hoechst 33258 fluorescent staining and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
